Company intelligence / Profile preview
Mint Pharmaceuticals
Mississauga, Ontario, Canadamintpharma.com ↗
- Ownership
- Private
- Employees
- ~92
- Development stage
- Commercial
01
Overview
Mint Pharmaceuticals is a Canadian generic pharmaceutical company that has helped avert 15 national drug shortages on 10 different molecules since 2014. During the COVID-19 pandemic, they collaborated with the Government of Canada to supply 7.5 million doses of hydroxychloroquine[5].
- Therapeutic areas
- GastroenterologyCardiovascularNeurologyInfectious Diseases
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Government of Canada (collaborated for hydroxychloroquine supply during COVID-19)
Beyond the preview
Go deeper on Mint Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Mint Pharmaceuticals.